Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb;65(2):55-69.
doi: 10.3349/ymj.2023.0131.

Beneficial Effects of Low-Grade Mitochondrial Stress on Metabolic Diseases and Aging

Affiliations
Review

Beneficial Effects of Low-Grade Mitochondrial Stress on Metabolic Diseases and Aging

Se Hee Min et al. Yonsei Med J. 2024 Feb.

Abstract

Mitochondria function as platforms for bioenergetics, nutrient metabolism, intracellular signaling, innate immunity regulators, and modulators of stem cell activity. Thus, the decline in mitochondrial functions causes or correlates with diabetes mellitus and many aging-related diseases. Upon stress or damage, the mitochondria elicit a series of adaptive responses to overcome stress and restore their structural integrity and functional homeostasis. These adaptive responses to low-level or transient mitochondrial stress promote health and resilience to upcoming stress. Beneficial effects of low-grade mitochondrial stress, termed mitohormesis, have been observed in various organisms, including mammals. Accumulated evidence indicates that treatments boosting mitohormesis have therapeutic potential in various human diseases accompanied by mitochondrial stress. Here, we review multiple cellular signaling pathways and interorgan communication mechanisms through which mitochondrial stress leads to advantageous outcomes. We also discuss the relevance of mitohormesis in obesity, diabetes, metabolic liver disease, aging, and exercise.

Keywords: Mitochondria; aging; diabetes; hormesis; obesity; stress.

PubMed Disclaimer

Conflict of interest statement

The authors have no potential conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1. Beneficial effects of low-grade mitochondrial stress on metabolic diseases and aging. Repeated exposure to low levels of mitochondrial stress induces a wide range of cytosolic and nuclear adaptive responses, which contribute to building resilience against higher levels of mitochondrial stress. These mitohormetic responses have been demonstrated to confer several health benefits, including the reduction of obesity and diabetes complications, delayed aging, and improved outcomes in the management of liver diseases. ROS, reactive oxygen species; UPRmt, mitochondrial unfolded protein response.
Fig. 2
Fig. 2. Molecular and cellular mechanisms of mitohormesis. Low-grade, multiple mitochondrial stresses induce mitohormetic responses that offer protection from metabolic diseases (obesity, diabetes, and liver diseases) and aging-related pathologies. These adaptive responses include ROS production, mitochondria biogenesis and dynamics (mitophagy, mitochondrial fusion and fission), alterations in mitochondrial membrane potential, activation of cytosolic Ca2+-dependent signaling pathways, mitochondrial unfolded protein responses, and inter-organ mitochondria stress response via the release of mitokines. ROS, reactive oxygen species; MDPs, mitochondria-derived peptides.
Fig. 3
Fig. 3. Examples of inter-organ mitohormetic responses. (A) In C. elegans, deletion of mitochondrial respiration component cytochrome c oxidase-1 (cco-1) in neurons extends life span by the induction of mitochondria unfolded protein responses (UPRmt) in the intestine. Secretory factors released by stressed neurons (serotonin, FLP-2, and Wnt ligand/EGL-20) mediate these inter-organ mitochondria stress responses. (B) In mice, deletion of mitochondrial ribosomal protein CRIF1 in the skeletal muscles and hypothalamic POMC neurons improves obesity, insulin resistance, and hepatic steatosis by enhancing fatty acid oxidation and lipolysis in the adipose tissue and liver. These interorgan communication in mitochondrial stress responses occur by means of mitokine GDF15 and the sympathetic nervous system.

Similar articles

References

    1. Osellame LD, Blacker TS, Duchen MR. Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab. 2012;26:711–723. - PMC - PubMed
    1. Keipert S, Lutter D, Schroeder BO, Brandt D, Ståhlman M, Schwarzmayr T, et al. Endogenous FGF21-signaling controls paradoxical obesity resistance of UCP1-deficient mice. Nat Commun. 2020;11:624. - PMC - PubMed
    1. Wajner M, Amaral AU. Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies. Biosci Rep. 2015;36:e00281. - PMC - PubMed
    1. Wiederkehr A, Wollheim CB. Minireview: implication of mitochondria in insulin secretion and action. Endocrinology. 2006;147:2643–2649. - PubMed
    1. Ristow M. Oxidative metabolism in cancer growth. Curr Opin Clin Nutr Metab Care. 2006;9:339–345. - PubMed